John Hernandez
Insider
First SEC filing: Nov. 22, 2021 · Latest: Nov. 22, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 20, 2025 | RMD | A | 1,073 | · | · | 5,118 Direct | +26.53% | Acquired | |
| Aug. 18, 2025 | RMD | M | 2,575 | $148.90 | $383,418 | 6,620 Direct | +63.66% | Acquired | 69.8% (price as of ) |
| Aug. 18, 2025 | RMD | S | 2,575 | $287.10 | $739,282 | 4,045 Direct | -38.90% | Disposed | -11.9% (price as of ) |
| Aug. 18, 2025 | RMD | M | 2,575 | · | · | 0 Direct | -100.00% | Disposed | |
| Nov. 20, 2024 | RMD | A | 1,083 | · | · | 4,045 Direct | +36.56% | Acquired | |
| Nov. 16, 2023 | RMD | A | 884 | · | · | 2,962 Direct | +42.54% | Acquired | |
| Nov. 16, 2023 | RMD | A | 2,575 | $148.90 | $383,418 | 2,575 Direct | · | Acquired | |
| Nov. 16, 2022 | RMD | A | 1,122 | · | · | 2,078 Direct | +117.36% | Acquired |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 18, 2025 | RMD | ResMed Common Stock Options | ResMed Common Stock | $148.90 | Nov. 16, 2030 | 2,575 | Disposed |
| Nov. 16, 2023 | RMD | ResMed Common Stock Options | ResMed Common Stock | $148.90 | Nov. 16, 2030 | 2,575 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Nov. 22, 2021 | RMD | ResMed Common Stock | 956 | Direct |